阿拓莫兰对成人急性髓样白血病化疗患者肝功能损伤的预防作用观察

doi:10.3969/j.issn.1672-5069.2016.06.020

Abstract

Liu Ben，Hou Qiuyue.. Protective effect of atomolan to liver injuries in patients with acute myeloid leukemia receiving chemotherapy[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(6): 717-719.

[1] Klepin HD，Pardee TS. Acute myeloid leukemia. Hematol Oncol Clin N Am，2015，23（4）:633-654.
[2] Nishioka A，Kubota Y，Sueoka E，et al. Reversible liver steatosis induced by chemotherapy of mixed-phenotype acute leukemia. Intern Med，2016，55（8）:1025-1026.
[3] Zhang Q，Yu NN，Wen LJ，et al. A preliminary study of apparent diffusion coefficient in chemotherapy-induced liver damage. Eur J Radiol，2012，81（11）:2943-2946.
[4] 于春虎，高阳. 阿拓莫兰在化疗中护肝作用评价.药品评价， 2008，5（7）:313-314.
[5] 中华医学会血液学分会. 成人急性髓样白血病（非急性早幼粒细胞白血病）中国诊疗指南（2011年版）. 中华血液学杂志，2011，32（11）:804-807.
[6] Jan M，Snyder TM，Corces-Zimmerman MR，et al. Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia. Sci Translat Med，2012，4（149）:118-123.
[7] 李宝军. MA与DA方案治疗成人急性髓样白血病的疗效对比. 山东医药，2011，51（49）:110-111.
[8] 俞文娟，秘营昌，卞寿庚，等. 中剂量阿糖胞苷诱导治疗成人急性髓样白血病. 中华血液学杂志，2005，26（2）:109-111.
[10] Kuzieva GZ，Kholmatova NM，Shevchenko LI，et al. Lipid peroxidation and antioxidant system status in patients with acute myeloblast leukemia and toxic damage of the liver. Likarska Sprava，2009，32（12）:454-459.
[11] Thatishetty AV，Agresti N，O'Brien CB. Chemotherapy-induced hepatotoxicity. Clin Liver Dis，2013，17（4）:671-686.
[12] 许晓东，胡翠华，常乃柏，等. 成人急性髓细胞白血病免疫分型特点及临床预后分析. 中国实验诊断学，2010，14（3）:423-426.
[13] 高开波，童勇，冯春. 不同剂量还原型谷胱甘肽在急性髓样白血病化疗中对肝功能保护作用的临床观察. 中国药房，2010，32（24）:2242-2243.
[14] Allan JM，Wild CP，Rollinson S，et al. Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia. Proc Nat Acad Sci USA，2001，98（20）:11592-11597.
[15] 杨清，邓斌，严少男. 还原型谷胱甘肽对大鼠酒精性肝损伤的保护作用. 药品评价，2008，5（7）:315-316.
[16] 张斌，王轩，李增才，等. 还原型谷胱甘肽阿拓莫兰对供肝组织损伤的保护作用. 中国组织工程研究与临床康复，2010，14（18）:3239-3242.

[1]	Huang Shiying, Liang Shuang, Wei Yanghui, et al. Efficacy of CAO chemotherapy regimen combined with high frequency focused ultrasound ablation in the treatment of children with hepatoblastoma at stage III/IV [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 569-572.
[2]	Wu Quanlin, He Yaopeng. Efficacy of ERCP-guided radiofrequency ablation combined with chemotherapy in treatment of patients with cholangiocarcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 537-540.
[3]	Tong Xin, Fan Hua. Efficacy of bicyclic alcohol on liver function in gastric cancer patients with chemotherapy-induced liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 625-626.
[4]	Ruan Shengting, Xia Guangyun.. Application of glycyrrhizic acid magnesium and reduced glutathinone in treatment of patients with anti-rheumatoid arthritis-induced liver injuries [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(5): 608-609.
[5]	Wang Haiyan, Chen Hai.. Drug-induced liver injuries in patients with schizophrenics taking haloperidol: Difference between different ABO blood groups [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(6): 722-723.
[6]	Hao wensheng，Zhang dongcheng，Gui dong，et al.. Efficacy and safety of S-1 plus oxaliplatin as first-line treatment in patients with advanced intrahepatic cholangiocarcinomas [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(4): 415-417.
[7]	Fu Qingchun. Scoring system for diagnosis of drug-induced liver injuries [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(6): 569-572.
[8]	Guo Xiuli, Yao Shiwei, Zhang Jun. Clinical effect of magnesium isoglycyrrhizinate combined with reduced glutathione in the treatment of patients with chemotherapeutic drug-induced liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(6): 575-579.
[9]	Lyu Yufeng. Effectiveness and impact on liver functions of two different chemotherapy regimens in treatment of patients with pulmonary tuberculosis complicated by chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(5): 493-497.
[10]	Xu Changfeng, Chen Sihan, Li Ling. Progress in chemotherapy and molecular targeted therapy in the treatment of patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(3): 228-231.
[11]	Xu Yonghua, Xu Jingci, Yang Lixia, at al.. Application of apparent diffusion coefficient for predicting response of hepatic metastases to chemotherapy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2012, 15(5): 421-423.

Protective effect of atomolan to liver injuries in patients with acute myeloid leukemia receiving chemotherapy

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 11

Recommended Articles

Metrics

Comments